STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
41 hedge funds and large institutions have $7.34M invested in Statera Biopharma, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
41
Holding in Top 10
–
Calls
$535K
Puts
$68K
Top Buyers
| 1 | +$15.9K | |
| 2 | +$13.6K | |
| 3 | +$10K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$8.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8K |
Top Sellers
| 1 | -$144K | |
| 2 | -$88.9K | |
| 3 | -$60K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$29.4K |
| 5 |
Goldman Sachs
New York
|
-$27.3K |